129 related articles for article (PubMed ID: 6543230)
1. [Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity].
Murayama Y
Gan No Rinsho; 1984 Dec; 30(15):1879-82. PubMed ID: 6543230
[TBL] [Abstract][Full Text] [Related]
2. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.
Rose DP; Chlebowski RT; Connolly JM; Jones LA; Wynder EL
Cancer Res; 1992 Oct; 52(19):5386-90. PubMed ID: 1394142
[TBL] [Abstract][Full Text] [Related]
3. Plasma sex hormone-binding globulin (SHBG) and obesity in breast cancer patients.
Murayama Y
Cancer Detect Prev; 1983; 6(4-5):425-33. PubMed ID: 6686084
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of estradiol as a marker for breast cancer risk assessment.
Jones LA; Ota DM; Jackson GA; Jackson PM; Kemp K; Anderson DE; McCamant SK; Bauman DH
Cancer Res; 1987 Oct; 47(19):5224-9. PubMed ID: 3621208
[TBL] [Abstract][Full Text] [Related]
5. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
6. [Sex hormone-binding globulin in breast cancer].
Suminaga Y; Morimoto T; Komaki K; Mori T; Monden Y
Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):875-82. PubMed ID: 2398880
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
[TBL] [Abstract][Full Text] [Related]
8. Sex hormone-binding globulin (SHBG) and estradiol cross-talk in breast cancer cells.
Fortunati N; Catalano MG
Horm Metab Res; 2006 Apr; 38(4):236-40. PubMed ID: 16700004
[TBL] [Abstract][Full Text] [Related]
9. Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III.
Jordan VC; Fritz NF; Tormey DC
Cancer Res; 1987 Aug; 47(16):4517-9. PubMed ID: 3607780
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure.
Costantino L; Catalano MG; Frairia R; Carmazzi CM; Barbero M; Coluccia C; Donadio M; Genta F; Drogo M; Boccuzzi G; Fortunati N
Breast Cancer Res Treat; 2009 Apr; 114(3):449-56. PubMed ID: 18437557
[TBL] [Abstract][Full Text] [Related]
11. The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.
Stewart HJ; Forrest AP; Gunn JM; Hamilton T; Langlands AO; McFadyen IJ; Roberts MM
Eur J Cancer (1965); 1980; Suppl 1():83-8. PubMed ID: 7032945
[No Abstract] [Full Text] [Related]
12. Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer.
Fortunati N; Catalano MG; Boccuzzi G; Frairia R
Mol Cell Endocrinol; 2010 Mar; 316(1):86-92. PubMed ID: 19770023
[TBL] [Abstract][Full Text] [Related]
13. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values.
Endogenous Hormones and Breast Cancer Collaborative Group
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1457-61. PubMed ID: 14693737
[TBL] [Abstract][Full Text] [Related]
14. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
[TBL] [Abstract][Full Text] [Related]
15. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.
McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K
Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323
[No Abstract] [Full Text] [Related]
16. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
17. The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer.
Spicer D; Pike MC; Henderson BE
Oncology (Williston Park); 1990 Dec; 4(12):49-54, 59; discussion 59, 62. PubMed ID: 2149039
[TBL] [Abstract][Full Text] [Related]
18. [Relation between hormone dependence and metastasis in breast cancer--SHBG assay in the study of breast cancer metastases].
Murayama Y
Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):7-9. PubMed ID: 3611893
[No Abstract] [Full Text] [Related]
19. Relationship between sex hormone binding globulin and estrogen receptors in breast cancer.
Plymate SR; Stutz FH; Fariss BL
J Clin Oncol; 1984 Jun; 2(6):652-4. PubMed ID: 6539364
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum estrogen levels in women during tamoxifen therapy.
Lum SS; Woltering EA; Fletcher WS; Pommier RF
Am J Surg; 1997 May; 173(5):399-402. PubMed ID: 9168075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
